Get the Stockscreener App
13.00
3.83%
0.48
Daxor Corporation stock is traded at $13.00, with a volume of 541.
It is up +3.83% in the last 24 hours and up +1.33% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$12.52
Open:
$13.0915
24h Volume:
541
Relative Volume:
0.09
Market Cap:
$62.88M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
43.29
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+0.31%
1M Performance:
+1.33%
6M Performance:
+78.08%
1Y Performance:
+47.39%
1-Day Range:
$13.00
$13.09
1-Week Range:
$11.52
$13.09
52-Week Range:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.00 | 62.41M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Will Daxor Corporation (DX5) stock see valuation expansionTrade Entry Report & Real-Time Stock Movement Alerts - newser.com
Can Daxor Corporation stock rebound after recent weaknessWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Will breakout in Daxor Corporation lead to full recovery2025 Key Lessons & High Accuracy Investment Signals - newser.com
Will Daxor Corporation (DX5) stock enhance shareholder valueMarket Trend Summary & Daily Technical Forecast Reports - newser.com
Is Daxor Corporation (DX5) stock positioned for digital growth eraAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
What data driven models say about Daxor Corporation’s futurePortfolio Risk Summary & Long-Term Growth Plans - newser.com
Will Daxor Corporation stock continue upward momentumMarket Movers & AI Driven Stock Reports - newser.com
Developing predictive dashboards with Daxor Corporation dataTrade Entry Summary & Technical Pattern Alert System - newser.com
Will Daxor Corporation outperform the marketJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
Will Daxor Corporation (DX5) stock see insider accumulationJuly 2025 Earnings & Smart Investment Allocation Insights - newser.com
Is Daxor Corporation stock a buy before product launchesEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Is Daxor Corporation a good long term investmentEarnings Season Recap & Affordable Trading Strategies - earlytimes.in
How strong is Daxor Corporation (DX5) stock earnings growthTrade Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
Understanding the Setup: (DXR) and Scalable Risk - news.stocktradersdaily.com
Will Daxor Corporation (DX5) stock test record highs in 2025Weekly Risk Summary & Free Accurate Trade Setup Notifications - newser.com
Can Daxor Corporation stock sustain free cash flow growthPortfolio Risk Summary & Reliable Price Action Trade Plans - newser.com
Is Daxor Corporation (DX5) stock cheap vs fundamentalsTrade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Will Daxor Corporation stock maintain dividend yieldJuly 2025 Short Interest & High Conviction Trade Alerts - newser.com
How high can Daxor Corporation stock go2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Will Daxor Corporation stock benefit from AI adoptionWeekly Loss Report & High Return Stock Watch Alerts - newser.com
Daxor Corporation recovery potential after sell offTrade Ideas & Safe Capital Preservation Plans - newser.com
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):